On a Roll: FDA Calls Sage's Depression Drug a Breakthrough Post author:Sam Post published:February 6, 2018 Post category:BioPharma This is the second Breakthrough Therapy designation granted to Sage since 2016. Source: BioSpace You Might Also Like Agile Therapeutics, Inc. Reports Fourth Quarter And Full Year 2016 Financial Results March 8, 2017 ORIC Pharmaceuticals Snags $50 Million to Advance Lead Asset for Treatment-Resistant Cancers February 20, 2018 AstraZeneca Gets in on ADC Therapeutics' Mega $200M Funding Round October 22, 2017
ORIC Pharmaceuticals Snags $50 Million to Advance Lead Asset for Treatment-Resistant Cancers February 20, 2018